These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11460203)

  • 21. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand?
    Tordoff JM; Norris PT; Reith DM
    Value Health; 2005; 8(3):201-8. PubMed ID: 15877592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost efficiency, factor interchange, and technical progress in US specialized hospital pharmacies.
    Okunade AA; Suraratdecha C
    Health Econ; 1998 Jun; 7(4):363-71. PubMed ID: 9683096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Financial assessment of device for the preparation of intravenous mixtures in hospital pharmacy].
    Casado Collado A; Luengo Pascual L; Herdman M; Bonafont Pujol X; Clemente Bautista S; Jódar Masanés R; Napal Lecumberri V; Serrano Padilla G
    Farm Hosp; 2004; 28(4):243-50. PubMed ID: 15369434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling strategies for reducing pharmaceutical costs in hospital.
    MacIntyre CR; Sindhusake D; Rubin G
    Int J Qual Health Care; 2001 Feb; 13(1):63-9. PubMed ID: 11330446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacy resident involvement in prior-authorization drug request adjudication.
    Britnell SR; Brown JN; Hashem MG; Hale JC; Bryan WE; Hammond JM; Britt RB
    Am J Health Syst Pharm; 2018 Dec; 75(23 Supplement 4):S87-S93. PubMed ID: 30228166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inventory management of compounded sterile preparation areas.
    Turaga P; Arrowood S; Brown AT
    Am J Health Syst Pharm; 2011 Sep; 68(17):1581, 1587-8. PubMed ID: 21856803
    [No Abstract]   [Full Text] [Related]  

  • 28. Relative costs of anesthesiologist prepared, hospital pharmacy prepared and outsourced anesthesia drugs.
    Jelacic S; Craddick K; Nair BG; Bounthavong M; Yeung K; Kusulos D; Knutson JA; Somani S; Bowdle A
    J Clin Anesth; 2017 Feb; 36():178-183. PubMed ID: 28183562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A commentary on high-cost drugs.
    de Leon RF
    Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration.
    Tanner DJ
    Rev Infect Dis; 1984; 6 Suppl 4():S924-37. PubMed ID: 6522928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Length of stay has minimal impact on the cost of hospital admission.
    Taheri PA; Butz DA; Greenfield LJ
    J Am Coll Surg; 2000 Aug; 191(2):123-30. PubMed ID: 10945354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost savings from dose rounding of biologic anticancer agents in adults.
    Winger BJ; Clements EA; DeYoung JL; O'Rourke TJ; Claypool DL; Vachon S; VanDyke TH; Zimmer-Young J; Kintzel PE
    J Oncol Pharm Pract; 2011 Sep; 17(3):246-51. PubMed ID: 20332175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy component of a hospital end-product cost-accounting system.
    Smith JE; Sheaffer SL; Meyer GE; Giorgilli F
    Am J Hosp Pharm; 1988 Apr; 45(4):835-43. PubMed ID: 3376968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing comprehensive pharmaceutical services at an academic tertiary care hospital.
    Janning SW; Stevenson JG; Smolarek RT
    Am J Health Syst Pharm; 1996 Mar; 53(5):542-7. PubMed ID: 8697014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs and savings of investigational drug services.
    McDonagh MS; Miller SA; Naden E
    Am J Health Syst Pharm; 2000 Jan; 57(1):40-3. PubMed ID: 10630555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involving physicians in efforts to control pharmaceutical expenditures.
    Shulkin DJ; McGourty ME; Bourret J
    Med Interface; 1995 Aug; 8(8):85-7, 90. PubMed ID: 10144777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidisciplinary approach to reducing costs in a health system.
    Abramowitz PW; Woller TW; Daniels CE; Somani SM; Phelps P; McComb RC
    Am J Health Syst Pharm; 1997 May; 54(10):1196-9. PubMed ID: 9161630
    [No Abstract]   [Full Text] [Related]  

  • 38. Getting the most out of low-dose syringe prefilling of a high-cost biotechnology agent.
    Lu A; Chan L
    Hosp Pharm; 1994 Apr; 29(4):353, 356-7. PubMed ID: 10133464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued cost justification of an operating room satellite pharmacy.
    Fiala D; Grady KP; Smigla R
    Am J Hosp Pharm; 1993 Mar; 50(3):467-9. PubMed ID: 8442463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing.
    Bond CA; Raehl CL; Franke T
    Pharmacotherapy; 2001 Feb; 21(2):129-41. PubMed ID: 11213848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.